Related references
Note: Only part of the references are listed.TNF in the era of immune checkpoint inhibitors: friend or foe?
Allen Y. Chen et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
Danah Al Shaer et al.
PHARMACEUTICALS (2020)
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity
Fabian Richter et al.
MABS (2019)
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
Juliane Medler et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches
Samira Pourtaghi-Anvarian et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2019)
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
James O'Connell et al.
NATURE COMMUNICATIONS (2019)
ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study
Mark C. Genovese et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Qiang Guo et al.
BONE RESEARCH (2018)
Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-) inhibitors
Athanasios Tragiannidis et al.
MYCOSES (2017)
Identification of novel peptides against TNF-α using phage display technique and in silico modeling of their modes of binding
Ali Akbar Alizadeh et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
Jee Un Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Single domain antibodies for the knockdown of cytosolic and nuclear proteins
Thomas Boeldicke
PROTEIN SCIENCE (2017)
Bivalent llama single-Domain antibody Fragments against Tumor necrosis Factor have Picomolar Potencies due to intramolecular interactions
Els Beirnaert et al.
FRONTIERS IN IMMUNOLOGY (2017)
Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening
Hadley Mouhsine et al.
SCIENTIFIC REPORTS (2017)
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
Michela Silacci et al.
MABS (2016)
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
Grigory A. Efimov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides
Shusheng Geng et al.
IMMUNOLOGIC RESEARCH (2015)
Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide
Stefan Luzi et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
Sophie Steeland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology
Ali Akbar Alizadeh et al.
ADVANCED PHARMACEUTICAL BULLETIN (2015)
Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis
Olivia Meira Dias et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2014)
A Novel Small-molecule Tumor Necrosis Factor α Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model
Li Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Novel Phage-Library-Selected Peptide Inhibits Human TNF-α Binding to Its Receptors
Jlenia Brunetti et al.
MOLECULES (2014)
Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial
Patrick Durez et al.
PLOS ONE (2014)
Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
Evripidis Kaltsonoudis et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis
Fiona E. McCann et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Membrane versus Soluble Isoforms of TNF-α Exert Opposing Effects on Tumor Growth and Survival of Tumor-Associated Myeloid Cells
Shidrokh Ardestani et al.
CANCER RESEARCH (2013)
Phage display as a technology delivering on the promise of peptide drug discovery
Maryam Hamzeh-Mivehroud et al.
DRUG DISCOVERY TODAY (2013)
Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
Shi Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab
Shuaiyi Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
Laurent Peyrin-Biroulet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Felix Nau et al.
PLOS ONE (2013)
The Role of TNF-alpha and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
Antonella Galeone et al.
SCIENTIFIC WORLD JOURNAL (2013)
Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy
T. Bessissow et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Clinical impact of serum proteins on drug delivery
Felix Kratz et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL
M. Grunert et al.
CELL DEATH & DISEASE (2012)
Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice
Tetsuya Nomura et al.
JOURNAL OF CONTROLLED RELEASE (2011)
A strategy for high-level expression of a single-chain variable fragment against TNFα by subcloning antibody variable regions from the phage display vector pCANTAB 5E into pBV220
Tao Yang et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Structure-Based Discovery of Natural-Product-like TNF-alpha Inhibitors
Daniel Shiu-Hin Chan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening
Hwanho Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Phage display: Concept, innovations, applications and future
Jyoti Pande et al.
BIOTECHNOLOGY ADVANCES (2010)
Progress in phage display: evolution of the technique and its applications
Tomaz Bratkovic
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody
Kirstin A. Zettlitz et al.
MABS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Solution of the Structure of the TNF-TNFR2 Complex
Yohei Mukai et al.
SCIENCE SIGNALING (2010)
Crystallization and preliminary X-ray analysis of the tumour necrosis factor α-tumour necrosis factor receptor type 2 complex
Yohei Mukai et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2009)
TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia-Reperfusion Injury and Trauma
E. Esposito et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Antagonists of TNF action: clinical experience and new developments
Roland E. Kontermann et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
Structure-Function Relationship of Tumor Necrosis Factor (TNF) and Its Receptor Interaction Based on 3D Structural Analysis of a Fully Active TNFR1-Selective TNF Mutant
Yohei Mukai et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Improved Isolation of Anti-rhTNF-α scFvs from Phage Display Library by Bioinformatics
Wei Chen et al.
MOLECULAR BIOTECHNOLOGY (2009)
Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Marcia L. Moss et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Creation and x-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-α antagonist
Hiroko Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection
Jonathan Zalevsky et al.
JOURNAL OF IMMUNOLOGY (2007)
A novel human scFv fragment against TNF-α from de novo design method
Hong Chang et al.
MOLECULAR IMMUNOLOGY (2007)
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma
D. G. Jackson-Bernitsas et al.
ONCOGENE (2007)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
IK682, a tight binding inhibitor of TACE
Xiaoda Niu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Analysing the effect of novel therapies on cytokine expression in experimental arthritis
RO Williams et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2005)
Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases
H Kamata et al.
CELL (2005)
A review of the use of infliximab to manage cutaneous dermatoses
AK Gupta et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2004)
Function and regulation of tumor necrosis factor receptor type 2
I Carpentier et al.
CURRENT MEDICINAL CHEMISTRY (2004)
The role of interleukin-1 in the pathogenesis of rheumatoid arthritis
J. Kay et al.
RHEUMATOLOGY (2004)
Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen
T Okamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Identification of anti-TNFα peptides with consensus sequence
J Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Inactivation of TNF signaling by rationally designed dominant-negative TNF variants
PM Steed et al.
SCIENCE (2003)
Anti-TNF-α-induced systemic lupus syndrome
M Debandt et al.
CLINICAL RHEUMATOLOGY (2003)
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α
PH Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Antibody arrays for high-throughput screening of antibody-antigen interactions
RMT de Wildt et al.
NATURE BIOTECHNOLOGY (2000)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
Share Paper
